Otezla® Approved by FDA, EMA, Health Canada
Otezla® Approved by FDA, EMA, Health Canada
4 Pagesert.com Copyright © 1994-2015 by ERT. All rights reserved. Rev August 2015 CASE STUDY: OTEZLA ® APPROVED BY FDA, EMA, HEALTH CANADA Data Collected on ERT eCOA System In 2014, Celgene Corporation received FDA approval of OTEZLA ® (apremilast), the company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate. OTE
